Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
IPO Year:
Exchange: NASDAQ
Website: organigram.ca
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/17/2024 | Speculative Buy | Canaccord Genuity | |
4/15/2024 | Neutral → Buy | Alliance Global Partners | |
1/13/2023 | Hold → Buy | Stifel | |
1/12/2022 | Hold → Speculative Buy | Canaccord Genuity | |
1/12/2022 | $5.70 → $5.30 | Overweight | Cantor Fitzgerald |
12/8/2021 | $5.50 → $5.70 | Overweight | Cantor Fitzgerald |
Beena Goldenberg, CEO to retire at the end of the Company's fiscal year Board of Directors expresses confidence in the Company's strategic direction and leadership team Comprehensive CEO selection process will be initiated to identify a successor Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), ("the Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the "Board") to advance Organigram's st
Record gross revenue of $102.8 million and record net revenue of $65.6 million Adjusted EBITDA1 of $4.9 million Net income of $42.5 million Increase in anticipated Motif cost synergies to $15 million from $10 million Total cash position of $83.4 million2 and negligible debt Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 ("Q2 Fiscal 2025"). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross r
Wins gold medal for Blood Orange, Yuzu & Vanilla and platinum medal for Mango, Pineapple & Coconut Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC beverages. High Spirits Awards is a competition launched by L.A. Spirits Awards in 2023 to identify and reward excellence among the growi
Award recognizes exceptional export growth, product innovation, and global market leadership Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), ("the Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce it has been named Exporter of the Year by Opportunities New Brunswick ("ONB") as part of the 2025 New Brunswick Export Awards, ONB's flagship annual event recognizing the successes and innovative approaches of New Brunswick's many exporting companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505021217/en/ This honour recognizes Organigram's significant growth in international cannab
Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I96766371 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a co
Urges new government to work with industry to help legal cannabis industry fuel Canada's economic growth Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, congratulates Prime Minister Mark Carney on the results of the 2025 federal election and urges policymakers to act swiftly in recognizing and elevating the cannabis sector as a critical pillar in Canada's economic growth strategy. "Congratulations to Prime Minister Carney on his party's victory and to Opposition Leader Pierre Poilievre for his party's strong showing, as well as all who put themselves forward as candidates," said Beena Goldenberg, CEO of Organigr
SHRED, Edison, and Trailblazer Recognized for Excellence in Branding and Product Innovation Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce that three of its consumer brands — SHRED, Edison, and Trailblazer — earned honours at the recent CNB Leadership Conference and the Cannabis NB Cup. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424458385/en/ Inspired by the legacy events that have shaped cannabis culture over the years, the Cannabis NB Cup celebrates the best in grow — with winners chosen by those who matter most, our co
OG Investor Session includes presentations from Organigram Global's senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram Global"), Canada's #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422567368/en/ To access a recording of the event please click here or visit www.organigram.ca/investors. "This session was a
Clear majority believes Canada's $7.4 billion legal cannabis industry should be empowered to grow amid rising global trade tensions Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada's economy through homegrown industries, including the legal cannabis sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250416457263/en/ The national survey, commissioned by Organigram Global and conducted by Abacus Data between April 3–8, 20251, arrives at a pivotal moment for Canad
Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram Global"), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key industry trends, and get a behind-the-scenes look at the innovation and strategy driving Organigram Global forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402